Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged versus intermittent meropenem infusion in critically ill patients with infection
ChiCTR-TRC-13003565Phase 4Completed
- Sponsor
- ICU Department of Qilu Hospital of Shandong University
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of meropenem in Infection (2 arms), sponsored by ICU Department of Qilu Hospital of Shandong University. Primary endpoints: Therapeutic effect and Pharmacoeconomics. Started Oct 2013; status: completed.
02
Drugs
meropenem
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR-TRC-13003565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003565.